Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

The agency recommended a total of 11 drugs at its July meeting, including five orphan drugs. 


EMA Recommends Five Orphan Drugs

Contract manufacturers await a promising pipeline of drug products to jump-start stagnant growth. 

Report: Dose CMOs Stuck in Idle

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

The advantages of single-use systems become clear as they become more broadly implemented.   

Single-Use Technologies Transform Biopharmaceutical Facilities and Manufacturing Equipment

ChargePoint Technology is expanding its US presence by opening a new office in San Francisco. 

ChargePoint Adds US Office

GSK plans to deliver up to 40 million doses of its quadrivalent flu vaccine for the 2017–2018 season.


GSK Ships Seasonal Influenza Vaccines for US Market

Gerresheimer’s glass and plastic prefillable syringes will come with an innovative, integrated, passive syringe safety solution, acquired through an exclusive licence from West Pharmaceutical Services.

Gerresheimer to Launch Innovative Syringe Safety Solution through Exclusive Licence from West

The company has entered into a settlement agreement with generic-drug companies to resolve patent litigation. 


Eli Lilly Resolves Patent Litigation Over Cialis

The acquisition will add recombinant-based influenza vaccine to Sanofi Pasteur’s portfolio

Sanofi Acquires Protein Sciences

ABEC increases the maximum capacity of its Custom Single Run Bioreactors to 4000 L, doubling the industry standard.

ABEC Releases 4000-L Single-Use Bioreactor

GE Healthcare’s Dharmacon business and CordenPharma contract manufacturing enter a strategic collaboration to accelerate the oligonucleotide development process.